Navigation Links
Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
Date:12/20/2010

MISSISSAUGA, Ontario, Dec. 20, 2010 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Philip W. Loberg, Valeant's former senior vice president and corporate controller, has been named to the role of interim chief financial officer, effective immediately, replacing Peggy Mulligan, former chief financial officer, who has elected to resign in order to pursue other interests.  The Company has initiated a search to identify a permanent replacement.

"The Board of Directors and I appreciate the contributions Peggy has made during these past few months involving the successful integration activities between Valeant and Biovail and we wish her well in her future endeavors," said J. Michael Pearson, chief executive officer.  "Phil has been an integral part of the Valeant finance department for over 10 years and played key roles in the successful integration of over eighteen acquisitions and several debt financings.  Under Phil's direction, Valeant implemented a turnaround strategy which included strengthening our financial systems and establishing strict internal controls at our various business units.  I am confident that our financial organization will operate seamlessly during this transition process."

Philip W. Loberg joined Valeant in 2000 as treasurer and was appointed chief financial officer of North America in 2006. In 2007, he was appointed to his most recent role of senior vice president, group financial controller, and in that role, Mr. Loberg has been responsible for the upgrading and retooling of the global finance department following restructurings and the disposition of non-performing assets.  In addition, Mr. Loberg simplified and streamlined the SEC compliance and reporting process and was instrumental in the integration of multiple new businesses throughout the global enter
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
2. Valeant Announces Pricing of Senior Notes
3. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
4. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
7. Valeant and Biovail Announce Results of Special Meetings of Shareholders
8. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
9. Valeant to Acquire Polish Products
10. Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
11. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... DIEGO , Aug. 4, 2015  MEI Pharma, Inc. ... clinical development of novel therapies for cancer, announced today that ... Officer, will present at the 2015 Wedbush PacGrow Healthcare Conference ... from Le Parker Meridien in New ... be accessed at www.meipharma.com . A replay will be ...
(Date:8/4/2015)... NEW YORK , Aug. 4, 2015  Delcath ... and medical device company focused on oncology with an ... cancers, announces that two abstracts summarizing data from studies ... of treatment with the Delcath Hepatic CHEMOSAT ® ... Association of Dermato Oncology (EADO) annual congress, which will be ...
(Date:8/4/2015)... DIEGO , Aug. 4, 2015 ... three-dimensional biology company focused on delivering scientific and ... that the Company has hired Paul Gallant ... vitro tissue service and product business. Mr. Gallant has ... experience in the drug discovery industry, most recently ...
Breaking Medicine Technology:MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 4Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3
... Purchases 933,022 shares of Common Stock at $15.00 per Share,Increases Ownership Stake to 19.9%." /> ... ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse ...
... China PharmaHub Corp. ("PharmaHub"), which has recently merged with World ... has changed its name to China PharmaHub Corp, and is ... under its new name with a new symbol, announced today ... a world leader in precision glass technology which can be ...
Cached Medicine Technology:Fosun Pharma Acquires $14 Million of Chindex Stock 2Fosun Pharma Acquires $14 Million of Chindex Stock 3Fosun Pharma Acquires $14 Million of Chindex Stock 4Fosun Pharma Acquires $14 Million of Chindex Stock 5Fosun Pharma Acquires $14 Million of Chindex Stock 6Fosun Pharma Acquires $14 Million of Chindex Stock 7Fosun Pharma Acquires $14 Million of Chindex Stock 8Fosun Pharma Acquires $14 Million of Chindex Stock 9UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh 2UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh 3UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh 4
(Date:8/4/2015)... Los Angeles, California (PRWEB) , ... August 04, ... ... bearing drawer slides to Los Angeles commercial customers. Finding reliable hardware can ... create unfortunate liabilities. When putting an office together or designing a new ...
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide ... Power Products is expanding its reach in Texas. Effective July 1st of this ... North Texas generator division. With the North Texas acquisition, Worldwide Power Products ...
(Date:8/4/2015)... ... 2015 , ... Many men are confused about the safety of testosterone replacement ... as a voice of authority for men seeking accurate information about testosterone. , ... and expertise in the safe and effective treatment of low testosterone. In recent years, ...
(Date:8/4/2015)... ... August 04, 2015 , ... Increasingly, ... Google” before calling a physician. In an effort to share more and better ... provider in Pennsylvania to publicly share patient satisfaction ratings and comments about its ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... mesothelioma patients whose cancer has come back: Retreatment may be a viable option. ... to read it now. , According to surgeons at the University of ...
Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:North Texas Acquisition Press Release 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2
... arrest the growth and spread of tumors, there have been ... instruction manual. In a new study, a team led ... able to prevent cancer genes from "hearing" those instructions, stifling ... online by the journal Nature , demonstrates that proteins ...
... and having trouble concentrating? Hormones might be to blame according ... Brain and Cognition . The study shows that high ... and learn the first such paper to report how ... the hormone on mature brain structures. "Although estrogen is ...
... of a limb, most patients experience the feeling of a phantom ... is still present. Damage to the nervous system, such as stroke, ... leg may feel as if it is in a completely different ... it is not. Cases of phantom limbs in non-amputees have previously ...
... motorcycle crashes were 1.5 times more likely to die ... many more of the African-American victims were wearing helmets ... study by Johns Hopkins researchers. Results of the ... issue of the American Journal of Surgery , ...
... have found that the costs of care for patients with ... than for patients who remained with hospice. Patients who disenroll ... care and be hospitalized. The results are published in ... Led by Melissa D.A. Carlson, PhD, Assistant Professor of ...
... By Serena Gordon HealthDay Reporter , THURSDAY, ... 24-year-old Ray Johnston was living his boyhood dream. He,d ... and plunked down on the courts of the National Basketball ... scout,s eye at a local tournament. But a small ...
Cached Medicine News:Health News:Researchers create first molecule-blocks key component of cancer genes' on-off switch 2Health News:Researchers create first molecule-blocks key component of cancer genes' on-off switch 3Health News:Can't focus? Maybe it's the wrong time of month 2Health News:Phantom limbs more common than previously thought 2Health News:Black motorcyclists -- even in helmets -- more likely to die in crashes 2Health News:Patients with cancer who stop hospice care boost health-care costs 2Health News:Experimental Leukemia Drug Proves a Slam Dunk 2Health News:Experimental Leukemia Drug Proves a Slam Dunk 3Health News:Experimental Leukemia Drug Proves a Slam Dunk 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: